clanger

What's Happening at Pfizer Right Now?

www.globes.co.il/serve...

Roche mulls Rosetta bid
The pharma giant may invest in or acquire the microRNA diagnostics developer.
Gali Weinreb 24 Sep 08 12:12
Roche Holding AG (SWX: RO), which is already is involved in an expensive takeover bid for Genentech Inc. (NYSE: DNA), has also begun deliberating a combination with Israeli microRNA-based diagnostics and therapeutics developer Rosetta Genomics Ltd. (Nasdaq:ROSG). Sources inform ''Globes'' that Roche representatives visited Rosetta's offices and negotiations for a possible investment or takeover are underway. Talks are in the early stage.
Rosetta declined to comment on the report.